Prevention of pharmaceutical drug misuse

DrugInfo newsletter, volume 7, number 2, December 2008

This issue of DrugInfo looks at the two most commonly misused types of pharmaceuticals, opioids and benzodiazepines, and examines prevention and early intervention strategies from the perspective of general practitioners, pharmacists and psychologists.

Download this newsletter in a print-friendly format [PDF: 630KB](new window)

To view this newsletter you will need Adobe Acrobat Reader. If you do not have Adobe Acrobat Reader (version 9.3), click on the link below and follow the instructions to install this free software:

Contents

Reconnexion: treating tranquilliser dependency, anxiety disorders and depression
Gwenda Cannard, Chief Executive Officer, Reconnexion, Victoria

Non-medical use of pharmaceutical drugs
Guest editorial by Dr Malcolm Dobbin, Senior Medical Adviser (Alcohol and Drugs), Mental Health and Drugs Division, Department of Human Services, Victoria

Trial of a new treatment for benzodiazepine withdrawal
Dr Martyn Lloyd-Jones, Specialist in Addiction Medicine,Department of Addiction Medicine, St Vincent’s Hospital, Victoria

"Doctor, I just need a script for Oxycontin thanks"
Dr Benny Monheit, Medical Director, Southcity Clinic, Drug and Alcohol Physician, Alfred Hospital, Victoria

Pharmaceutical misuse—one pharmacist’s perspective
Irvine Newton, Chairman, Harm Minimisation Committee, Pharmaceutical Society of Australia, Victoria

Non-steroidal anti-inflammatory drug toxicity secondary to codeine dependence
Dr Malcolm Dobbin, Senior Medical Adviser (Alcohol and Drugs), Mental Health and Drugs Division, Department of Human Services, Victoria

Psychological therapy: a non-drug alternative for the treatment of anxiety and substance use
Dr Hunter Mulcare, Psychologist, Clinical Services, Turning Point Drug and Alcohol Centre, Victoria